கிஷுே ஜாங் யூ News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from கிஷுே ஜாங் யூ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In கிஷுே ஜாங் யூ Today - Breaking & Trending Today
Results in blood cancer improved by ensuring gut integrity: Study ANI | Updated: Feb 13, 2021 19:54 IST Washington [US], February 13 (ANI): A solitary strain of Bacteroides fragilis altogether diminished graft-versus-host disease (GVHD) by ensuring gut integrity, suggested the findings of a new study led by cancer researchers of Medical University of South Carolina (MUSC). The findings reported in JCI Insight showed that even though bone marrow transplant can be a lifesaving procedure for patients with blood cancers; however, GVHD is a potentially fatal side effect of transplantation, and it has limited treatment options. This proof-of-concept study demonstrates that better treatment options may be on the horizon for patients with GVHD. ....
Single strain of bacteria may reduce the severity of graft-versus-host disease MUSC Hollings Cancer Center researchers found that a single strain of bacteria may be able to reduce the severity of graft-versus-host disease (GVHD), as reported online in February 2021 in JCI Insight. Bone marrow transplant can be a lifesaving procedure for patients with blood cancers. However, GVHD is a potentially fatal side effect of transplantation, and it has limited treatment options. This proof-of-concept study demonstrates that better treatment options may be on the horizon for patients with GVHD. Xue-Zhong Yu, M.D., associate director of Basic Science at Hollings Cancer Center, and lead author Hanief Sofi, Ph.D., realized that protecting the health of the gastrointestinal tract is a good target for reducing severe GVHD. ....
E-Mail IMAGE: Dr. Xue-Zhong Yu and his research team s findings suggest there could be a new way to protect bone marrow transplant recipients from graft-versus-host disease. view more Credit: MUSC Hollings Cancer Center MUSC Hollings Cancer Center researcher Yongxia Wu, Ph.D., identified a new target molecule in the fight against graft-versus-host disease (GVHD). Bone marrow transplant, a treatment for certain blood cancers, is accompanied by potentially life-threatening GVHD in nearly 50% of patients. A January 2021 paper published in Cellular and Molecular Immunology revealed that activating a molecule called STING may be a new approach to reduce GVHD. Xue-Zhong Yu, M.D., professor in the Department of Microbiology and Immunology, focuses on understanding the intricate immune mechanisms that regulate GVHD development and anti-tumor activity. ....
MUSC Hollings Cancer Center researcher Yongxia Wu, Ph.D., identified a new target molecule in the fight against graft-versus-host disease (GVHD). Bone. ....